Table 1.
Patient demographics.
| HSRT(n = 6) | |
|---|---|
| Sex | |
| Male | 4(67%) |
| Female | 2(33%) |
| Age(years) | |
| Mean(SD) | 76.7 |
| Median(range) | 77 |
| WHO performance status | |
| 0 | 3(50%) |
| 1 | 3(50%) |
| 2 | 0 |
| Histology before therapy | |
| Adenocarcinoma | 3(50%) |
| Squamous | 1(17%) |
| Unknown | 2(33%) |
| Tumor stage | |
| T1a | 3(50%) |
| T1b | 1(17%) |
| T2a | 2(33%) |
| Stage | |
| IA | 4(67%) |
| IB | 2(33%) |
| Tumor site | |
| Left lower lobe | 1(17%) |
| Left upper lobe | 3(50%) |
| Right lower lobe | 0 |
| Right middle lobe | 0 |
| Right upper lobe | 2(33%) |
Data are n (%) unless otherwise stated. HSRT, hypofractionated stereotactic radiotherapy.